Neil Harris Cohen, Director at Chemomab Therapeutics Ltd. (CMMB), bought 4,818 shares at $41.51 ($200K) on 2021-03-16, disclosed to the SEC on 2021-03-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.51 | 2,409 | $100K | 50.0% |
| 2 | $41.51 | 2,409 | $100K | 50.0% |
| Total | $41.51 avg | 4,818 | $200K | 100% |
| Filing → |
| CMMB | BUY | 2022-05-19 | $6K | — | Filing → |
| CMMB | BUY | 2022-03-15 | $26K | — | Filing → |
| CMMB | BUY | 2021-12-08 | $15K | — | Filing → |